These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 15625816)

  • 1. Deposition of coarse particles in cystic fibrosis: model predictions versus experimental results.
    Brown JS; Bennett WD
    J Aerosol Med; 2004; 17(3):239-48. PubMed ID: 15625816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional deposition of coarse particles and ventilation distribution in healthy subjects and patients with cystic fibrosis.
    Brown JS; Zeman KL; Bennett WD
    J Aerosol Med; 2001; 14(4):443-54. PubMed ID: 11791685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling breath-enhanced jet nebulizers to estimate pulmonary drug deposition.
    Wee WB; Leung K; Coates AL
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):387-96. PubMed ID: 23509934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimum peripheral drug deposition in patients with cystic fibrosis.
    Brand P; Meyer T; Häussermann S; Schulte M; Scheuch G; Bernhard T; Sommerauer B; Weber N; Griese M
    J Aerosol Med; 2005; 18(1):45-54. PubMed ID: 15741773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Posture on Regional Deposition of Coarse Particles in the Healthy Human Lung.
    Sá RC; Zeman KL; Bennett WD; Prisk GK; Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):423-31. PubMed ID: 25826480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.
    Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional Ventilation Is the Main Determinant of Alveolar Deposition of Coarse Particles in the Supine Healthy Human Lung During Tidal Breathing.
    Sá RC; Zeman KL; Bennett WD; Prisk GK; Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):322-331. PubMed ID: 28277885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough?
    Bos AC; van Holsbeke C; de Backer JW; van Westreenen M; Janssens HM; Vos WG; Tiddens HA
    PLoS One; 2015; 10(3):e0118454. PubMed ID: 25734630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate.
    Laube BL; Jashnani R; Dalby RN; Zeitlin PL
    Chest; 2000 Oct; 118(4):1069-76. PubMed ID: 11035679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis.
    Coates AL; Allen PD; MacNeish CF; Ho SL; Lands LC
    Chest; 2001 Apr; 119(4):1123-30. PubMed ID: 11296179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capturing the efficiency of vibrating mesh nebulizers: minimizing upper airway deposition.
    Sagalla RB; Smaldone GC
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):341-8. PubMed ID: 25105472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics.
    Hasan MA; Lange CF
    J Aerosol Med; 2007; 20(3):282-93. PubMed ID: 17894535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional deposition and regional ventilation during inhalation of pentamidine.
    O'Riordan TG; Smaldone GC
    Chest; 1994 Feb; 105(2):396-401. PubMed ID: 8306735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung deposition and respirable mass during wet nebulization.
    Sangwan S; Condos R; Smaldone GC
    J Aerosol Med; 2003; 16(4):379-86. PubMed ID: 14977428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of Particle Deposition by Pixel Analysis of 2D Gamma Scintigraphy Images.
    Bennett WD; Xie M; Zeman K; Hurd H; Donaldson S
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):211-8. PubMed ID: 25393109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon dioxide accumulation during small animal, whole body plethysmography: effects on ventilation, indices of airway function, and aerosol deposition.
    Kimmel EC; Whitehead GS; Reboulet JE; Carpenter RL
    J Aerosol Med; 2002; 15(1):37-49. PubMed ID: 12006144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice-to-men comparison of inhaled drug-aerosol deposition and clearance.
    Kolanjiyil AV; Kleinstreuer C; Kleinstreuer NC; Pham W; Sadikot RT
    Respir Physiol Neurobiol; 2019 Feb; 260():82-94. PubMed ID: 30445230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cystic fibrosis on inhaled aerosol boluses.
    Anderson PJ; Blanchard JD; Brain JD; Feldman HA; McNamara JJ; Heyder J
    Am Rev Respir Dis; 1989 Nov; 140(5):1317-24. PubMed ID: 2817594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative performance of two inhaler systems to assess distribution of convective ventilation by 99mTc-labeled aerosol scintigraphy in patients with airway obstruction.
    Fazzi P; Borsò E; Albertelli R; Mariani G; Giuntini C
    Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):428-36. PubMed ID: 19174757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.